Cambiar Investors LLC lowered its position in Aetna Inc. (NYSE:AET) by 13.5% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 258,484 shares of the company’s stock after selling 40,242 shares during the period. Cambiar Investors LLC owned approximately 0.08% of Aetna worth $41,102,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. State of Tennessee Treasury Department grew its position in shares of Aetna by 26.3% in the 2nd quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock worth $84,692,000 after buying an additional 116,280 shares during the last quarter. Banque Pictet & Cie SA purchased a new position in shares of Aetna in the 2nd quarter worth approximately $10,567,000. Pictet & Cie Europe SA purchased a new position in shares of Aetna in the 2nd quarter worth approximately $2,269,000. NBT Bank N A NY purchased a new position in shares of Aetna in the 2nd quarter worth approximately $215,000. Finally, Eaton Vance Management grew its position in shares of Aetna by 18.3% in the 2nd quarter. Eaton Vance Management now owns 1,050,685 shares of the company’s stock worth $159,526,000 after buying an additional 162,502 shares during the last quarter. 90.93% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Cambiar Investors LLC Has $41.10 Million Stake in Aetna Inc. (AET)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/11/13/cambiar-investors-llc-has-41-10-million-stake-in-aetna-inc-aet.html.

Aetna Inc. (NYSE AET) traded down $2.51 on Monday, hitting $172.61. 620,814 shares of the company traded hands, compared to its average volume of 2,580,000. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 0.53. Aetna Inc. has a 1 year low of $116.04 and a 1 year high of $184.98. The firm has a market cap of $56,290.00, a PE ratio of 17.15, a P/E/G ratio of 1.60 and a beta of 0.61.

Aetna (NYSE:AET) last posted its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The firm had revenue of $14.99 billion during the quarter, compared to analysts’ expectations of $15.12 billion. During the same period in the previous year, the business posted $2.07 EPS. The business’s revenue was down 5.0% compared to the same quarter last year. analysts forecast that Aetna Inc. will post 9.78 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Thursday, October 12th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.16%. The ex-dividend date of this dividend was Wednesday, October 11th. Aetna’s dividend payout ratio is currently 36.97%.

In related news, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction on Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the sale, the president now owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the completion of the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

AET has been the topic of a number of analyst reports. BidaskClub downgraded shares of Aetna from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Royal Bank Of Canada boosted their target price on shares of Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a research report on Friday, August 4th. Jefferies Group LLC reissued a “hold” rating and set a $163.00 target price (up previously from $157.00) on shares of Aetna in a research report on Friday, August 4th. Deutsche Bank AG boosted their target price on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research report on Monday, August 7th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $175.00 target price (up previously from $150.00) on shares of Aetna in a research report on Wednesday, August 9th. Eleven investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $170.34.

Aetna Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.